Dr. Alessandra Ferrajoli, MD
Claim this profileM D Anderson Cancer Center
Area of expertise
Chronic Lymphocytic Leukemia
Alessandra Ferrajoli, MD has run 5 trials for Chronic Lymphocytic Leukemia. Some of their research focus areas include:
Lymphoma
Alessandra Ferrajoli, MD has run 2 trials for Lymphoma.
Affiliated Hospitals
M D Anderson Cancer Center
University Of Texas MD Anderson Cancer Center
Clinical Trials Alessandra Ferrajoli, MD is currently running
Behavioral Interventions
for Chronic Lymphocytic Leukemia
To learn if exercise and weight management can help to improve feelings of fatigue in CLL survivors.
Recruiting
1 award
N/A
Venetoclax + BTK Inhibitors
for Chronic Lymphocytic Leukemia
This is a single center, open-label, phase II study of venetoclax (ABT-199) added to ibrutinib or acalabrutinib in patients with high-risk CLL who have received at least 12 months of ibrutinib or acalabrutinib monotherapy. The study will estimate the therapeutic efficacy of venetoclax consolidation in patients who have detectable CLL after receiving ibrutinib or acalabrutinib for at least 12 months and who have high risk CLL.
Recruiting
1 award
Phase 2
More about Alessandra Ferrajoli, MD
Clinical Trial Related
4 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Alessandra Ferrajoli, MD has experience with
- Venetoclax
- Pirtobrutinib
- Exercise And Weight Management
- Fit Bit
- Questionnaires
- Ruxolitinib Phosphate
Breakdown of trials Alessandra Ferrajoli, MD has run
Chronic Lymphocytic Leukemia
Lymphoma
B-Cell Lymphoma
Childhood Blood Disease
Mixed-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Alessandra Ferrajoli, MD specialize in?
Alessandra Ferrajoli, MD focuses on Chronic Lymphocytic Leukemia and Lymphoma. In particular, much of their work with Chronic Lymphocytic Leukemia has involved del(17p) positive patients, or patients who are TP53 positive.
Is Alessandra Ferrajoli, MD currently recruiting for clinical trials?
Yes, Alessandra Ferrajoli, MD is currently recruiting for 2 clinical trials in Houston Texas. If you're interested in participating, you should apply.
Are there any treatments that Alessandra Ferrajoli, MD has studied deeply?
Yes, Alessandra Ferrajoli, MD has studied treatments such as Venetoclax, Pirtobrutinib, Exercise and Weight Management.
What is the best way to schedule an appointment with Alessandra Ferrajoli, MD?
Apply for one of the trials that Alessandra Ferrajoli, MD is conducting.
What is the office address of Alessandra Ferrajoli, MD?
The office of Alessandra Ferrajoli, MD is located at: M D Anderson Cancer Center, Houston, Texas 77030 United States. This is the address for their practice at the M D Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.